Dr. Xuyu Qian's breakthrough analysis of 18 million brain cells advances understanding of human brain development

(Press-News.org) PHILADELPHIA, Pennsylvania, USA – July 8, 2025 – Genomic Press today published in Genomic Psychiatry an in-depth interview with Dr. Xuyu Qian, Assistant Professor at the University of Pennsylvania Perelman School of Medicine and Children's Hospital of Philadelphia, whose pioneering research in brain organoid technology and spatial transcriptomics is transforming our understanding of human brain development and neurodevelopmental disorders.

Dr. Qian's recent landmark study, published in Nature (2025), represents one of the most comprehensive analyses of human brain development to date. Using cutting-edge MERFISH (multiplexed error-robust fluorescence in situ hybridization) technology, his team analyzed over 18 million single cells to create an unprecedented developmental atlas of the human cerebral cortex.

From Anime Inspiration to Scientific Innovation

Growing up in Nanjing, China, in a family of artists—his father a high school art teacher and his mother a skilled artisan of brocade crafts—Dr. Qian's path to neuroscience began unexpectedly. The Japanese anime series Evangelion sparked his passion for biotechnology during high school. "It was the most life-defining moment for me," he recalls in the Genomic Press interview. "It was the first time I realized that biology and biotechnology could reshape the world."

This unconventional inspiration led him to pursue biomedical engineering at Worcester Polytechnic Institute, where he graduated in just three years. Despite having no background in neuroscience or stem cell biology, he joined Dr. Hongjun Song's lab at Johns Hopkins University, where he developed pioneering methods to generate human brain organoids from stem cells—a foundation that would shape his entire research trajectory.

Breakthrough Organoid Technology with Global Impact

Dr. Qian's brain organoid protocols have revolutionized the field, with his methods now cited over 2,000 times. These protocols enable researchers worldwide to grow miniature human brain-like structures in the laboratory, providing an unprecedented window into human brain development and disease.

Perhaps most notably, his organoid work played a crucial role during the 2015-2016 Zika virus outbreak. Dr. Qian's team was among the first to provide experimental evidence that Zika could directly cause microcephaly and other brain abnormalities. The Centers for Disease Control and Prevention (CDC) referenced his study when declaring that Zika causes congenital disabilities, informing public health guidelines that advised pregnant women to avoid affected regions.

"Knowing that my research helped prevent Zika-related harm—and may even have saved lives—is something I take immense pride in," Dr. Qian reflects.

Mapping the Human Brain at Single-Cell Resolution

During his postdoctoral work with Dr. Christopher Walsh at Boston Children's Hospital, Dr. Qian pursued his interest in human brain development using spatial transcriptomics. His recent Nature publication represents a tour de force in the field, analyzing preserved human brain samples to construct a developmental atlas of the human cerebral cortex at unprecedented resolution.

"My research focuses on understanding how the human cerebral cortex develops and how this process goes awry in neurodevelopmental disorders," explains Dr. Qian. "Conventional animal and cell culture models often fail to capture the unique features of human cortical development, which has limited our understanding of human-specific diseases."

The significance of this approach lies in its human-centric methodology. While traditional neuroscience has relied heavily on animal models, Dr. Qian's work demonstrates the critical importance of studying human brain tissue directly. His spatial transcriptomics approach allows researchers to see not just which genes are active in individual cells, but precisely where those cells are located within the developing brain—information crucial for understanding how complex brain structures form.

Building a Collaborative Research Program

Named to the Forbes 30 Under 30 list, Dr. Qian represents a new generation of scientists committed to collaborative, open science. His philosophy of generous collaboration and credit-sharing has fostered numerous productive partnerships. "I genuinely enjoy working with others and believe in leaning on the expertise of collaborators rather than trying to learn and master everything myself," he notes.

As he establishes his new laboratory at the University of Pennsylvania, Dr. Qian's research program will integrate three key strategies: brain organoid models, spatial omics technologies, and human genetics. By combining these advanced techniques, his lab aims to identify the developmental programs disrupted in conditions such as malformations of cortical development and autism spectrum disorder.

"In the short term, my lab will focus on uncovering the mechanisms that drive the specification of cortical area-specific neuronal subtypes," Dr. Qian explains. "My long-term goal is to identify the developmental programs disrupted in these disorders and build a foundation for future therapeutic strategies."

Science Communication and Public Engagement

Beyond his laboratory achievements, Dr. Qian is committed to science communication and outreach. He has built a substantial following on the Chinese video platform Bilibili, where his channel has over 370,000 subscribers. Through these videos, he makes complex neuroscience concepts accessible to younger audiences, inspiring the next generation of scientists.

This commitment to public engagement reflects his broader vision for science. "Human life is far too short to unravel the universe's mysteries," he observes. "There is so much to discover, but not enough time to see it all." This sense of urgency drives his focused approach to research and his commitment to advancing human brain science as rapidly as possible.

Future Directions and Therapeutic Promise

Looking ahead, Dr. Qian's work holds immense promise for developing new therapeutic strategies for neurodevelopmental disorders. By understanding how the human brain develops at the cellular and molecular level, his research could lead to earlier diagnosis, better prediction of disease risk, and ultimately, more effective treatments for conditions that affect millions of children worldwide.

His unique combination of technical innovation, collaborative spirit, and human-centric approach positions him as one of neuroscience's most promising emerging leaders, destined to unravel fundamental mysteries of human brain development and disease.

Dr. Xuyu Qian's Genomic Press interview is part of a larger series called Innovators & Ideas that highlights the people behind today's most influential scientific breakthroughs. Each interview in the series offers a blend of cutting-edge research and personal reflections, providing readers with a comprehensive view of the scientists shaping the future. By combining a focus on professional achievements with personal insights, this interview style invites a richer narrative that both engages and educates readers. More information on the research leaders and rising stars featured in our Innovators & Ideas – Genomic Press Interview series can be found at: https://genomicpress.com

The Genomic Press Interview in Genomic Psychiatry titled "Xuyu Qian: Understanding human brain development and diseases using human-based approaches," is freely available via Open Access on 8 July 2025 in Genomic Psychiatry at the following hyperlink: https://doi.org/10.61373/gp025k.0062

About Genomic Psychiatry: Genomic Psychiatry: Advancing Science from Genes to Society (ISSN: 2997-2388, online and 2997-254X, print) represents a paradigm shift in genetics journals by interweaving advances in genomics and genetics with progress in all other areas of contemporary psychiatry. Genomic Psychiatry publishes high-quality medical research articles from any area within the continuum that goes from genes and molecules to neuroscience, clinical psychiatry, and public health.

Visit the Genomic Press Virtual Library: https://issues.genomicpress.com/bookcase/gtvov/

Our full website is at: https://genomicpress.com

END